Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis

BackgroundTransplant-associated thrombotic microangiopathy (TA-TMA) is a dangerous and life-threatening complication in patients undergoing hematopoietic stem cell transplantation (HSCT). Eculizumab has been used in the treatment of TA-TMA, and several studies have confirmed the benefit of Eculizuma...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rui Zhang, Meng Zhou, Jiaqian Qi, Wenjing Miao, Ziyan Zhang, Depei Wu, Yue Han
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	Eculizumab terminal complement inhibitor transplant-associated thrombotic microangiopathy hematopoietic stem cell transplantation efficacy safety
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.564647/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!